FDA Must Take Action On Omnitrope Review, Court Says; Will Plan B Follow?
This article was originally published in The Tan Sheet
Executive Summary
The case against FDA over the Plan B switch review delay will likely benefit from the precedent of a D.C. federal court ruling April 10 upholding PDUFA review deadlines as mandatory